2023
- McCoy KS, Blind J, Johnson T, Olson P, Raterman L, Bai S, Eisner M, Sheikh SI, Druhan S, Young C, Pasley K Clinical change 2 years from start of elexacaftor-tezacaftor-ivacaftor in severe cystic fibrosis. Pediatr Pulmonol 2023 Jan 17
- McCoy KS, Blind J, Johnson T, Olson P, Raterman L, Bai S, Eisner M, Sheikh SI, Druhan S, Young C, Pasley K Clinical change 2 years from start of elexacaftor-tezacaftor-ivacaftor in severe cystic fibrosis. Pediatr Pulmonol 2023 Jan 17
- McGrattan KE, Shell RD, Hurst-Davis R, Young SD, O'Brien E, Lavrov A, Wallach S, LaMarca N, Reyna SP, Darras BT Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment. J Neuromuscul Dis 2023 Apr 17
- Pasley K, Krivchenia K, Dell ML, McCoy KS, Paul GR Clinical management of pediatric patients with cystic fibrosis and autism spectrum disorder. Pediatr Pulmonol 2023 Jan 6
- Pasley K, Krivchenia K, Dell ML, McCoy KS, Paul GR Clinical management of pediatric patients with cystic fibrosis and autism spectrum disorder. Pediatr Pulmonol 2023 Jan 6
2022
- Benissan-Messan DZ, Ganapathi AM, Guo M, Henn MC, Keller BC, Howsare M, Rosenheck JP, Kirkby SE, Mokadam NA, Nunley D, Whitson BA Lung transplantation in the septuagenarian can be successfully performed though long-term results impacted by diseases of aging. Clin Transplant 2022 Jan 15 e14593
- Hall-Stoodley L, McCoy KS Biofilm aggregates and the host airway-microbial interface. Front Cell Infect Microbiol 2022 12 969326
- Hatef J, Hatef S, Drain JP, Tobias JD, Martin D, Shell R, Chase M, Beebe A, Samora W, Klamar J Protocol-driven early tracheal extubation in patients with flaccid neuromuscular scoliosis and pre-existing lung disease. Spine Deform 2022 Jan 24
- Jaganathan D, Bruscia EM, Kopp BT Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis. Int J Mol Sci 2022 Jul 13 23
- Mull ES, Cohen S, George A, Krivchenia K, Druhan S, Baker PB 3rd, Kopp B Cryptogenic organizing pneumonia: In the setting of Staphylococcus aureus endocarditis. Pediatr Pulmonol 2022 Sep 18
- Palacios S, Krivchenia K, Eisner M, Young B, Ramilo O, Mejias A, Lee S, Kopp BT Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection. Pediatr Pulmonol 2022 Jul 1
- Palacios S, Krivchenia K, Eisner M, Young B, Ramilo O, Mejias A, Lee S, Kopp BT Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection. Pediatr Pulmonol 2022 Jul 1
- Paul GR, Hayes D Jr, Tumin D, Gulati I, Jadcherla S, Splaingard ML What Are the Factors Affecting Total Sleep Time During Video Polysomnography in Infants? Am J Perinatol 2022 Jun 39 853-860
- Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros 2022 Aug 22
- Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, Heintz J, Kirkby SE, McCoy KS, Papachristou GI, Patel A, Singh VK, Hart PA Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. J Cyst Fibros 2022 Aug 22
- Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol 2022 Feb 27 14 411-419
- Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol 2022 Nov 29
- Sheikh S, Britt RD Jr, Ryan-Wenger NA, Khan AQ, Lewis BW, Gushue C, Ozuna H, Jaganathan D, McCoy K, Kopp BT Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis. Pediatr Pulmonol 2022 Nov 29
- Wisniewski BL, Aylward SC, Jordan CO, Kopp BT, Paul GR Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor/Tezacaftor/Ivacaftor initiation in a preadolescent with cystic fibrosis. J Cyst Fibros 2022 Feb 4
- Zampoli M, Kashirskaya N, Karadag B, Filho LVRFDS, Paul GR, Noke C Global access to affordable CFTR modulator drugs: Time for action! J Cyst Fibros 2022 Mar 24
- Zhang S, Shrestha CL, Robledo-Avila F, Jaganathan D, Wisniewski BL, Brown N, Pham H, Carey K, Amer AO, Hall-Stoodley L, McCoy KS, Bai S, Partida-Sanchez S, Kopp BT Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor. Eur Respir J 2022 Oct 20
Show More